Neutron dose in and out of 18 MV photon fields

被引:8
|
作者
Ezzati, A. O. [1 ]
Studenski, M. T. [2 ]
机构
[1] Univ Tabriz, Fac Phys, Tabriz, Iran
[2] Univ Miami, Dept Radiat Oncol, Miami, FL USA
关键词
High energy photons; Neutron contamination dose; Out-of-field dose; Neutron capture gamma; Monte Carlo; RADIATION-THERAPY; ELEKTA LINACS; VARIAN; RADIOTHERAPY; ACCELERATORS; SPECTRA;
D O I
10.1016/j.apradiso.2017.01.046
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
In radiation therapy, neutron contamination is an undesirable side effect of using high energy photons to treat patients. Neutron contamination requires adjustments to the shielding requirements of the linear accelerator vault and contributes to the risk of secondary malignancies in patients by delivering dose outside of the primary treatment field. Using MCNPX, an established Monte Carlo code, manufacturer blueprints, and the most up to date ICRP neutron dose conversion factors, the neutron spectra, neutron/photon dose ratio, and the neutron capture gamma ray dose were calculated at different depths and off axis distances in a tissue equivalent phantom. Results demonstrated that the neutron spectra and dose are dependent on field size, depth in the phantom, and off-axis distance. Simulations showed that because of the low neutron absorption cross section of the linear accelerator head materials, the contribution to overall patient dose from neutrons can be up to 1000 times the photon dose out of the treatment field and is also dependent on field size and depth. Beyond 45 cm off axis, the dependence of the neutron dose on field size is minimal. Neutron capture gamma ray dose is also field size dependent and is at a maximum at a depth of about 7 cm. It is important to remember that when treating with high energy photons, the dose from contamination neutrons must be considered as it is much greater than the photon dose.
引用
收藏
页码:186 / 192
页数:7
相关论文
共 50 条
  • [21] Clinical Context of Neutron Dose Contribution From 10MV FFF Vs 15MV Photon Beams
    Vickress, J.
    Zeng, G.
    Sankreacha, R.
    [J]. MEDICAL PHYSICS, 2020, 47 (06) : E718 - E718
  • [22] Relative biological damage in and out of field of 6, 10 and 18 MV clinical photon beams
    Ezzati, A. O.
    [J]. EUROPEAN PHYSICAL JOURNAL PLUS, 2016, 131 (08):
  • [23] Relative biological damage in and out of field of 6, 10 and 18 MV clinical photon beams
    A. O. Ezzati
    [J]. The European Physical Journal Plus, 131
  • [24] Assessment of skyshine photon dose rates from 9 and 18 MV medical linear accelerators
    Rostampour, N.
    Jafari, S.
    Saeb, M.
    Keshtkar, M.
    Shokrani, P.
    Ahnasi, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2018, 16 (04): : 499 - 503
  • [25] On the discrepancies between Monte Carlo dose calculations and measurements for the 18 MV Varian photon beam
    Chibani, Omar
    Ma, C. -M. Charlie
    [J]. MEDICAL PHYSICS, 2007, 34 (04) : 1206 - 1216
  • [26] Experimental measurements of dose modulation induced by a localized magnetic field on 18 MV photon beam
    Hsi, WC
    Chu, JCH
    Reiffel, L
    Moyer, D
    Saxena, AV
    [J]. MEDICAL PHYSICS, 2003, 30 (06) : 1509 - 1510
  • [27] Peripheral dose measurements for 6 and 18 MV photon beams on a linear accelerator with multileaf collimator
    Mazonakis, Michalis
    Zacharopoulou, Fotini
    Varveris, Haralambos
    Damilakis, John
    [J]. MEDICAL PHYSICS, 2008, 35 (10) : 4396 - 4403
  • [28] Study of reliability of TLDs for the photon dose mapping in reactor neutron fields for BNCT
    Gambarini, G.
    Gallivanone, F.
    Carrara, A.
    Nagels, S.
    Vogdander, L.
    Hampel, G.
    Pirola, L.
    [J]. RADIATION MEASUREMENTS, 2008, 43 (2-6) : 1118 - 1122
  • [29] Neutron and photon spectrometry in monoenergetic neutron fields
    Neumann, S
    Böttger, R
    Guldbakke, S
    Matzke, M
    Sosaat, W
    [J]. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2002, 476 (1-2): : 353 - 357
  • [30] Measurement of photon and neutron doses outside the treatment field for prostate patients undergoing 18 MV IMRT
    Reft, C
    Muller-Runkel, R
    Myrianthopoulos, L
    [J]. MEDICAL PHYSICS, 2005, 32 (06) : 2059 - 2060